Cardiac arrest in the setting of diet pill consumption

American Journal of Emergency Medicine

Volumn 26, Issue 6, 2008, Pages 732.e1-732.e3

  Makaryus, John N ^a   Makaryus, Amgad N ^a  

^a NORTH SHORE UNIVERSITY HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PHENTERMINE;

ADRENERGIC SYSTEM; ADULT; ANAMNESIS; ANGIOCARDIOGRAPHY; ARTICLE; BLOOD EXAMINATION; CASE REPORT; CORONARY CARE UNIT; DEFIBRILLATION; ELECTROCARDIOGRAM; EMERGENCY WARD; FEMALE; FOLLOW UP; HEART ARREST; HEART EJECTION FRACTION; HEART ELECTROPHYSIOLOGY; HEART INFARCTION; HEART VENTRICLE ENDDIASTOLIC PRESSURE; HEART VENTRICLE FIBRILLATION; HEART VENTRICLE TACHYCARDIA; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HUMAN; NORADRENERGIC SYSTEM; OBESITY; PILL; PRIORITY JOURNAL; WEIGHT REDUCTION;

EID: 46149099562     PISSN: 07356757     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajem.2007.10.040     Document Type: Article

References (19)

1. Ogden C.L., Carroll M.D., Curtin L.R., McDowell M.A., Tabak C.J., and Flegal K.M. Prevalence of overweight and obesity in the United States, 1999-2004. JAMA 295 13 (2006) 1549-1555
2. Van Winkle W. Letter to Endo Products, 5 January 1946. In: New drug application. No. 5632 vol. 1.1 (1943), U.S. Food and Drug Administration, Rockville (Md)
3. Colman E. Anorectics on trial: a half century of federal regulation of prescription appetite suppressants. Ann Intern Med 143 5 (2005) 380-385
4. Wangsness M. Pharmacological treatment of obesity: past, present, and future. Minn Med 83 11 (2000) 21-26
5. Shekelle P.G., Morton S.C., Maglione M., Suttorp M., Tu W., Li Z., et al. Pharmacological and surgical treatment of obesity. Evid Rep Technol Assess 103 (2004) 1-6
6. Kokkinos J., and Levine S.R. Possible association of ischemic stroke with phentermine. Stroke 24 2 (1993) 310-313
7. Bray G.A., and Greenway F.L. Current and potential drugs for treatment of obesity. Endocrine Reviews 20 6 (1999) 805-875
8. Kaplan L.M. Pharmacological therapies for obesity. Gastroenterol Clin North Am 34 1 (2005) 91-104
9. O'Connor A.D., Rusyniak D.E., and Bruno A. Cerebrovascular and cardiovascular complications of alcohol and sympathomimetic drug abuse. Med Clin North Am 89 6 (2005) 1343-1358
10. Henry J.B. Clinical diagnosis and management by laboratory methods (2001), Saunders, Philadelphia
11. Jacobs L.J. Reversible dilated cardiomyopathy induced by methamphetamine. Clin Cardiol 12 (1989) 725-727
12. Packe G.E., Garton M.J., and Jennings K. Acute myocardial infarction caused by intravenous amphetamine abuse. Br Heart J. 64 (1990) 23-24
13. Hong R., Matsuyama E., and Nur K. Cardiomyopathy associated with the smoking of crystal methamphetamine. JAMA 265 (1991) 1152-1154
14. Qasim A., Townend J., and Davis M.K. Ecstasy induced acute myocardial infarction. Heart 85 (2001) E10
15. Werner J. Poisoning with the recreational drug paramethoxyamphetamine ("death"). Med J Aust 174 9 (2001 May 7) 453-455
16. Drake W.M., and Broadhurst P.A. QT-interval prolongation with ecstasy. S Afr Med J. 86 (1996) 180-181
17. Hung M.J., Kuo L.T., and Cherng W.J. Amphetamine-related acute myocardial infarction due to coronary artery spasm. Int J Clin Pract 57 1 (2003) 62-64
18. El Menyar A.A. Drug-induced myocardial infarction secondary to coronary artery spasm in teenagers and young adults. J Postgrad Med 52 1 (2006) 51-56
19. He S.Y., Matoba R., Fujitani N., Sodesaki K., and Onishi S. Cardiac muscle lesions associated with chronic administration of methamphetamine in rats. Am J Forensic Med Pathol 17 2 (1996) 155-162